Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
IPL 2026 has been an absolute spectacle and are delivering everything a cricket fan could desire. Fierce battles, nail-biting finishes and relentless competition have defined this tournament ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results